Conformationally constrained analogues of diacylglycerol .13. Protein kinase C ligands based on templates derived from 2,3-dideoxy-L-erythro(threo)-hexono-1,4-lactone and 2-deoxyapiolactone

被引:13
作者
Lee, J
Lewin, NE
Acs, P
Blumberg, PM
Marquez, VE
机构
[1] NIH,NATL CANC INST,MED CHEM LAB,DIV BASIC SCI,BETHESDA,MD 20892
[2] NIH,NATL CANC INST,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,DIV BASIC SCI,BETHESDA,MD 20892
关键词
D O I
10.1021/jm960525v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present investigation, the last two possible modes of generating conformationally semirigid diacylglycerol (DAG) analogues embedded into five-membered ring lactones as templates III and IV are investigated. The first two templates studied in previous investigations corresponded to 2-deoxyribonolactone (template I) and 4,4-disubstituted gamma-butyrolactone (template II), with the latter producing potent protein kinase C (PK-C) ligands with low nanomolar binding affinities. The templates reported in this work correspond to 2,3-dideoxy-L-erythro- or -threo-hexono-1,4-lactone (template III) and 2-deoxyapiolactone (template IV). Compounds constructed with the dideoxy-L-erythro- or -threo-hexono-1,4-lactone template were synthesized stereospecifically from tri-O-acetyl-L-glucal and L-galactono-1,4-lactone, respectively. Compounds constructed with the 2-deoxyapiolactone template were synthesized stereoselectively from di-O-isopropylidene-alpha-D-apiose. Inhibition of the binding of [H-3]phorbol-12,13-dibutyrate to PK-C alpha showed that only the threo-isomer, 5-O-tetradecanoyl-2,3-dideoxy-L-threo-hexono-1,4-lactone (2) was a good PK-C ligand (K-i = 1 mu M). The rest of the ligands had poorer affinities with K-i values between 10 and 28 mu M. With these results, the order of importance of five-membered ring lactones as competent templates for the construction of semirigid DAG surrogates with effective PK-C binding affinity can be established as II much greater than I similar to III > IV.
引用
收藏
页码:4912 / 4919
页数:8
相关论文
共 23 条
[1]   COMPLEXITIES OF THE PROTEIN-KINASE-C PATHWAY [J].
BLUMBERG, PM .
MOLECULAR CARCINOGENESIS, 1991, 4 (05) :339-344
[2]   PREPARATION OF 3-DEOXY-ALDONOLACTONES BY HYDROGENOLYSIS OF ACETYLATED ALDONOLACTONES [J].
BOCK, K ;
LUNDT, I ;
PEDERSEN, C .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1981, 35 (03) :155-162
[3]  
CAREY FA, 1996, CARBOHYD RES, V3, P205
[4]   PROTEIN-KINASE-C - A QUESTION OF SPECIFICITY [J].
DEKKER, LV ;
PARKER, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (02) :73-77
[5]  
FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783
[6]  
FORD DA, 1990, J BIOL CHEM, V265, P12280
[7]  
KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489
[8]  
KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298
[9]  
LEE C, 1991, J BIOL CHEM, V266, P22837
[10]   Conformationally constrained analogues of diacylglycerol .11. Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template [J].
Lee, J ;
Wang, SM ;
Milne, GWA ;
Sharma, R ;
Lewin, NE ;
Blumberg, PM ;
Marquez, VE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :29-35